The bactericidal activity of carbon monoxide-releasing molecules against helicobacter pylori

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tavares, Ana F ^a   Parente, Margarida R ^a   Justino, Marta C ^a   Oleastro, Monica ^b   Nobre, Ligia S ^a   Saraiva, Ligia M ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CARBON MONOXIDE RELEASING MOLECULE 2; CARBON MONOXIDE RELEASING MOLECULE 3; CARBONYL DERIVATIVE; CLARITHROMYCIN; METRONIDAZOLE; UNCLASSIFIED DRUG; UREASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; IN VIVO STUDY; INNATE IMMUNITY; LETHAL DOSE; MACROPHAGE; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULE; MONOTHERAPY; MOUSE; NONHUMAN;

ANTI-BACTERIAL AGENTS; CARBON MONOXIDE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HELICOBACTER PYLORI; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; OXYGEN CONSUMPTION; UREASE;

EID: 84891332779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083157     Document Type: Article

References (35)

1. Graham DY (2000) Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 35 Suppl 12: 90-97
2. Fischer W, Prassl S, Haas R (2009) Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr Top Microbiol Immunol 337: 129-171
3. Stingl K, De Reuse H (2005) Staying alive overdosed: how does Helicobacter pylori control urease activity? Int J Med Microbiol 295: 307-315
4. Zanotti G, Cendron L (2010) Functional and structural aspects of Helicobacter pylori acidic stress response factors. IUBMB Life 62: 715-723
5. Rimbara E, Fischbach LA, Graham DY (2011) Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 8: 79-88
6. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, et al. (2013) Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 62: 34-42
7. Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, et al. (2007) Pharmacologic induction of heme oxygenase-1. Antioxid Redox Signal 9: 2227-2239
8. Chung SW, Liu X, Macias AA, Baron RM, Perrella MA (2008) Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118: 239-247
9. Wegiel B, Hanto DW, Otterbein LE (2013) The social network of carbon monoxide in medicine. Trends Mol Med 19: 3-11
10. Motterlini R, Otterbein LE (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743
11. Mann BE (2010) Carbon Monoxide: An Essential Signalling Molecule: Springer. 247-285 p
12. Romao CC, Blattler WA, Seixas JD, Bernardes GJ (2012) Developing drug molecules for therapy with carbon monoxide. Chem Soc Rev 41: 3571-3583
13. Motterlini R, Mann BE, Foresti R (2005) Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 14: 1305-1318
14. Johnson TR, Mann BE, Teasdale IP, Adams H, Foresti R, et al. (2007) Metal carbonyls as pharmaceuticals? [Ru(CO)3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry. Dalton Trans: 1500-1508
15. Nobre LS, Seixas JD, Romao CC, Saraiva LM (2007) Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob Agents Chemother 51: 4303-4307
16. Desmard M, Davidge KS, Bouvet O, Morin D, Roux D, et al. (2009) A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. Faseb J 23: 1023-1031
17. Zacharia VM, Shiloh MU (2012) Effect of carbon monoxide on Mycobacterium tuberculosis pathogenesis. Med Gas Res 2: 30
18. Nobre LS, Al-Shahrour F, Dopazo J, Saraiva LM (2009) Exploring the antimicrobial action of a carbon monoxide-releasing compound through wholegenome transcription profiling of Escherichia coli. Microbiology 155: 813-824
19. Tavares AF, Teixeira M, Romao CC, Seixas JD, Nobre LS, et al. (2011) Reactive oxygen species mediate bactericidal killing elicited by carbon monoxide-releasing molecules. J Biol Chem 286: 26708-26717
20. Albertson N, Wenngren I, Sjostrom JE (1998) Growth and survival of Helicobacter pylori in defined medium and susceptibility to Brij 78. J Clin Microbiol 36: 1232-1235
21. Gu Q, Xia HH, Wang WH, Wang JD, Wong WM, et al. (2004) Effect of cyclooxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. Aliment Pharmacol Ther 20: 675-681
22. Pankey GA, Sabath LD (2004) Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 38: 864-870
23. She FF, Su DH, Lin JY, Zhou LY (2001) Virulence and potential pathogenicity of coccoid Helicobacter pylori induced by antibiotics. World J Gastroenterol 7: 254-258
24. Nagata K, Tsukita S, Tamura T, Sone N (1996) A cb-type cytochrome-c oxidase terminates the respiratory chain in Helicobacter pylori. Microbiology 142 (Pt 7): 1757-1763
25. Smith H, Mann BE, Motterlini R, Poole RK (2011) The carbon monoxidereleasing molecule, CORM-3 (RU(CO)(3) CL(glycinate)), targets respiration and oxidases in Campylobacter jejuni, generating hydrogen peroxide. IUBMB Life 63: 363-371
26. Davidge KS, Sanguinetti G, Yee CH, Cox AG, McLeod CW, et al. (2009) Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J Biol Chem 284: 4516-4524
27. Ermler U, Grabarse W, Shima S, Goubeaud M, Thauer RK (1998) Active sites of transition-metal enzymes with a focus on nickel. Curr Opin Struct Biol 8: 749-758
28. Pope AJ, Toseland CD, Rushant B, Richardson S, McVey M, et al. (1998) Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro. Dig Dis Sci 43: 109-119
29. Phillips K, Munster DJ, Allardyce RA, Bagshaw PF (1993) Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori. J Clin Pathol 46: 372-373
30. Chu YT, Wang YH, Wu JJ, Lei HY (2012) Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance. Infect Immun 78: 4157-4165
31. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, et al. (2002) Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-24
32. Pena AC, Penacho N, Mancio-Silva L, Neres R, Seixas JD, et al. (2012) A novel carbon monoxide-releasing molecule fully protects mice from severe malaria. Antimicrob Agents Chemother 56: 1281-1290
33. Murray TS, Okegbe C, Gao Y, Kazmierczak BI, Motterlini R, et al. (2012) The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation. PLoS One 7: e35499
34. Sheikh SZ, Hegazi RA, Kobayashi T, Onyiah JC, Russo SM, et al. (2011) An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol 186: 5506-5513
35. Rodrigues SS, Seixas JD, Guerreiro B, Pereira NMP, Romao CC, et al. (2008) Prevention of gastric ulcer by carbon monoxide. In: ALFAMA -Investigacao e Desenvolvimento de Produtos Farmaceuticos L, editor